third generation glp 1 LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Dual and Triple Gut Peptide

The STEP 2 trial [2] , which included participants with type 2 diabetes, showed slightly more modest but still substantial results, with 9.6% average weight loss compared to 3.4% with placebo

Disruption of the hypothalamicpituitarygonadal axis, including hypogonadotropic hypogonadism, hyperprolactinaemia, thyroid dysfunction and exogenous androgen use, can impair spermatogenesis and may be reversible with targeted treatment

The doctors at Northwest Family Clinics provide GLP-1 prescribing and ongoing management as part of a comprehensive approach to weight management, nutrition counseling, and metabolic health

These habits may require a bit more discipline than simply using GLP-1s, but they have long-established science on their side